| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,113 |
7,170 |
$782K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,323 |
2,102 |
$299K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,403 |
3,037 |
$284K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,265 |
3,767 |
$277K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,281 |
1,083 |
$166K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
551 |
474 |
$141K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,656 |
1,477 |
$65K |
| 99051 |
|
3,549 |
3,199 |
$20K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
394 |
310 |
$19K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
863 |
766 |
$17K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
5,545 |
4,976 |
$17K |
| 87486 |
|
581 |
499 |
$12K |
| 87581 |
|
566 |
487 |
$12K |
| 87640 |
|
529 |
407 |
$10K |
| 99072 |
|
3,205 |
2,835 |
$9K |
| 99441 |
|
201 |
173 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
298 |
289 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
393 |
309 |
$6K |
| 87481 |
|
268 |
225 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
84 |
74 |
$4K |
| 99442 |
|
55 |
53 |
$4K |
| 87541 |
|
158 |
155 |
$4K |
| 87653 |
|
97 |
67 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
90 |
85 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
53 |
49 |
$853.79 |
| 36415 |
Collection of venous blood by venipuncture |
217 |
192 |
$591.60 |
| 87529 |
|
14 |
12 |
$554.36 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
60 |
36 |
$534.37 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
29 |
25 |
$522.78 |
| 81003 |
|
351 |
318 |
$475.42 |
| 87500 |
|
17 |
14 |
$361.39 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15 |
13 |
$301.74 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
28 |
26 |
$300.82 |
| 87563 |
|
14 |
12 |
$277.18 |
| 80053 |
Comprehensive metabolic panel |
15 |
15 |
$98.19 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13 |
13 |
$67.62 |
| 36416 |
|
18 |
17 |
$56.70 |
| 99000 |
|
196 |
164 |
$15.56 |
| 90694 |
|
17 |
14 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
17 |
14 |
$0.00 |